Quimi Daphne 4
4 · Amylyx Pharmaceuticals, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Purchase
Common Stock
2024-05-14$1.89/sh+2,750$5,184→ 2,750 total - Purchase
Common Stock
2024-05-15$1.89/sh+2,250$4,252→ 5,000 total